Home/Pipeline/Lenalidomide (Naxlen)

Lenalidomide (Naxlen)

Multiple Myeloma, Myelodysplastic Syndromes

ApprovedCommercial (India)

Key Facts

Indication
Multiple Myeloma, Myelodysplastic Syndromes
Phase
Approved
Status
Commercial (India)
Company

About Natco Pharma

Natco Pharma Limited is a vertically integrated pharmaceutical company with a mission to improve patient access to high-quality, affordable medicines. The company has established itself as a leader in the Indian generics market, with significant achievements in developing and commercializing complex generics, including oncology drugs like lenalidomide and hepatitis C treatments. Its strategic direction focuses on expanding its branded generics portfolio, strengthening its API business, and pursuing growth in regulated markets like the US through its subsidiary Natco Pharma USA.

View full company profile